Literature DB >> 1577173

Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour.

W J Curry1, C Shaw, C F Johnston, L Thim, K D Buchanan.   

Abstract

The primary structure of a novel human chromogranin A-derived tetradecapeptide, WE-14, possessing N-terminal tryptophanyl (W) and C-terminal glutamyl (E) residues was isolated from a hepatic metastasis of an human ileal carcinoid tumour. Human and bovine WE-14 are structurally identical, while rat, mouse and porcine analogues exhibit 93% homology. WE-14 is flanked by paired basic residues (KR) in all known chromogranin A sequences.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577173     DOI: 10.1016/0014-5793(92)80266-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Authors:  S K Mahata; D T O'Connor; M Mahata; S H Yoo; L Taupenot; H Wu; B M Gill; R J Parmer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.

Authors:  A P Heaney; W J Curry; K M Pogue; V L Armstrong; M Mirakhur; B Sheridan; C F Johnston; K D Buchanan; A B Atkinson
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

3.  Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies.

Authors:  Andreas Tartaglia; Guida M Portela-Gomes; Kjell Oberg; Paolo Vezzadini; Maria P Foschini; Mats Stridsberg
Journal:  Virchows Arch       Date:  2006-01-12       Impact factor: 4.064

4.  Chromogranin A is an autoantigen in type 1 diabetes.

Authors:  Brian D Stadinski; Thomas Delong; Nichole Reisdorph; Richard Reisdorph; Roger L Powell; Michael Armstrong; Jon D Piganelli; Gene Barbour; Brenda Bradley; Frances Crawford; Philippa Marrack; Sushil K Mahata; John W Kappler; Kathryn Haskins
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

5.  Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues.

Authors:  R Kirchmair; B Leitner; R Fischer-Colbrie; J Marksteiner; R Hogue-Angeletti; H Winkler
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

6.  Chromogranin A is a T cell antigen in human type 1 diabetes.

Authors:  Peter A Gottlieb; Thomas Delong; Rocky L Baker; Lisa Fitzgerald-Miller; Rebecca Wagner; Gabrielle Cook; Marian R Rewers; Aaron Michels; Kathryn Haskins
Journal:  J Autoimmun       Date:  2013-11-13       Impact factor: 7.094

7.  Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS.

Authors:  Jean C Lee; Vivian Hook
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

Review 8.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

9.  Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.

Authors:  Long Jin; Shuya Zhang; Jill Bayliss; Bernd Scheithauer; Xiang Qian; Ikuo Kobayashi; Mats Stridsberg; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  The post-translational processing of chromogranin A in the pancreatic islet: involvement of the eukaryote subtilisin PC2.

Authors:  S D Arden; N G Rutherford; P C Guest; W J Curry; E M Bailyes; C F Johnston; J C Hutton
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.